Yalin Yin, n/a

Xiamen Amoytop Biotech Co., Ltd
Xiamen, China (People's Republic)

Disclosure information not submitted.

Presentation(s):

• MON-228 - Dose Adjustment Strategy for the Long-Acting Growth Hormone Pegpesen Based on IGF-1 Level: A Poppk/PD Simulation Study

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT

• ORF47-04 - PK/PD Modeling, Efficacy and Safety of Pegpesen in Children with Non-Growth Hormone Deficiency Short Stature: A Basket Trial

  Monday, June 15, 2026
  2:00 PM - 2:15 PM CT